Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Publikováno v:
Antibodies, Vol 1, Iss 1, Pp 88-123 (2012)
Unmodified antibodies (abs) have been successful in the treatment of hematologic malignancies, but less so for the treatment of solid tumors. They trigger anti-tumor effects through their Fc-domains, and one way to improve their efficacy is to optimi